-+ 0.00%
-+ 0.00%
-+ 0.00%

Indaptus Therapeutics Director Matthew Charles McMurdo Files Initial Statement of Beneficial Ownership (Form 3)

Reuters·02/26/2026 15:57:39

Please log in to view news